Name: GSM8898821 - ccRCC tumor, Axitinib/Pembrolizumab treated, sc44
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/geo/info/disclaimer.html

GSM8898821 - ccRCC tumor, Axitinib/Pembrolizumab treated, sc44 | seqout